Rohan Mendonca

1.4k total citations · 1 hit paper
8 papers, 717 citations indexed

About

Rohan Mendonca is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rohan Mendonca has authored 8 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Rohan Mendonca's work include Mast cells and histamine (2 papers), Bone Metabolism and Diseases (2 papers) and Adenosine and Purinergic Signaling (1 paper). Rohan Mendonca is often cited by papers focused on Mast cells and histamine (2 papers), Bone Metabolism and Diseases (2 papers) and Adenosine and Purinergic Signaling (1 paper). Rohan Mendonca collaborates with scholars based in United States, Switzerland and Canada. Rohan Mendonca's co-authors include James T. Palmer, Leland C. Burrill, Heleen Scheerens, Paul A. Sprengeler, Paul G. Grothaus, Douglas A. Jeffery, M. D. Sweeney, Jill M. Spoerke, Zhengying Pan and Stacie A. Dalrymple and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and ChemMedChem.

In The Last Decade

Rohan Mendonca

8 papers receiving 694 citations

Hit Papers

Discovery of Selective Irreversible Inhibitors for Bruton... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rohan Mendonca United States 8 360 316 187 159 159 8 717
Rosalind H. Gunby Italy 13 316 0.9× 222 0.7× 85 0.5× 180 1.1× 42 0.3× 17 683
Matthew J. Saabye United States 8 267 0.7× 85 0.3× 56 0.3× 190 1.2× 69 0.4× 8 703
Gary Borzillo United States 12 492 1.4× 93 0.3× 93 0.5× 169 1.1× 52 0.3× 24 737
Paul Tapang United States 14 444 1.2× 79 0.3× 58 0.3× 236 1.5× 143 0.9× 29 773
Swaroop Vakkalanka United States 11 210 0.6× 266 0.8× 244 1.3× 132 0.8× 52 0.3× 46 551
Kilannin Krysiak United States 13 371 1.0× 126 0.4× 228 1.2× 240 1.5× 42 0.3× 26 794
Elisabeth Walsby United Kingdom 14 308 0.9× 131 0.4× 94 0.5× 216 1.4× 35 0.2× 25 559
Derek Wiswell United States 11 522 1.4× 77 0.2× 101 0.5× 459 2.9× 151 0.9× 14 934
Eloisi Caldas-Lopes United States 7 482 1.3× 106 0.3× 52 0.3× 152 1.0× 42 0.3× 11 737
Dennis Demont Netherlands 6 187 0.5× 280 0.9× 206 1.1× 67 0.4× 111 0.7× 8 490

Countries citing papers authored by Rohan Mendonca

Since Specialization
Citations

This map shows the geographic impact of Rohan Mendonca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohan Mendonca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohan Mendonca more than expected).

Fields of papers citing papers by Rohan Mendonca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohan Mendonca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohan Mendonca. The network helps show where Rohan Mendonca may publish in the future.

Co-authorship network of co-authors of Rohan Mendonca

This figure shows the co-authorship network connecting the top 25 collaborators of Rohan Mendonca. A scholar is included among the top collaborators of Rohan Mendonca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohan Mendonca. Rohan Mendonca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pei, Zhonghua, Rohan Mendonca, Lewis Gazzard, et al.. (2018). Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2). ACS Medicinal Chemistry Letters. 9(5). 417–421. 34 indexed citations
2.
Pan, Zhengying, Heleen Scheerens, Shyr‐Jiann Li, et al.. (2006). Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase. ChemMedChem. 2(1). 58–61. 517 indexed citations breakdown →
3.
Sperandio, David, Vincent W.‐F. Tai, Julia Lohman, et al.. (2006). Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 4085–4089. 9 indexed citations
4.
Palmer, James T., Robert M. Rydzewski, Rohan Mendonca, et al.. (2006). Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3434–3439. 17 indexed citations
5.
Rydzewski, Robert M., Leland C. Burrill, Rohan Mendonca, et al.. (2006). Optimization of Subsite Binding to the β5 Subunit of the Human 20S Proteasome Using Vinyl Sulfones and 2-Keto-1,3,4-oxadiazoles:  Syntheses and Cellular Properties of Potent, Selective Proteasome Inhibitors. Journal of Medicinal Chemistry. 49(10). 2953–2968. 35 indexed citations
6.
Boyer, Serge H., Bheemarao G. Ugarkar, Michael C. Matelich, et al.. (2005). Adenosine Kinase Inhibitors. 5. Synthesis, Enzyme Inhibition, and Analgesic Activity of Diaryl-erythro-furanosyltubercidin Analogues. Journal of Medicinal Chemistry. 48(20). 6430–6441. 32 indexed citations
7.
Robichaud, Joël, Renata M. Oballa, Peppi Prasit, et al.. (2003). A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K. Journal of Medicinal Chemistry. 46(17). 3709–3727. 66 indexed citations
8.
Mendonca, Rohan, Shankar Venkatraman, & James T. Palmer. (2002). Novel route to the synthesis of peptides containing 2-amino-1′-hydroxymethyl ketones and their application as cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(20). 2887–2891. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026